
News from optometrytimes.com
Top optometrytimes.com News

United States · United States Nanoscope Therapeutics submitted the first modules of a biologics license application for MCO-010, an investigational gene therapy to treat severe vision loss in retinitis pigmentosa, to the FDA, according to a press release.See the Story
Nanoscope Begins Rolling Submission of Biologics License Application for RP Gene Therapy
100% Center coverage: 2 sources

Viatris Provides Update on Phase 3 Study of MR-139 for Blepharitis
100% Center coverage: 2 sources

FDA · United StatesUnder the terms of the agreement, Kowa receives exclusive rights to develop and commercialize NCX 470 in the US and all other territories of the world excluding Japan, China, Korea, and Southeast Asia.See the Story
Nicox and Kowa Sign Agreement for Exclusive Rights to Glaucoma Treatment NCX 470
100% Center coverage: 1 sources